EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Patient‐Derived 3D Heart‐On‐a‐Chip Model of Dilated Cardiomyopathy With Embedded Bead‐Based Mapping of Tissue Contractility

Ali Mousavi iD, Ludovic Mouttet iD, Shihao Cui, Yasaman Hekmatnia iD, Mehran Mottahedi iD, Ida Derish, Naimeh Rafatian iD, Mark Aurousseau, Gregor Andelfinger, Renzo Cecere, Houman Savoji iD

Advanced Healthcare Materials · 2026-10 · 15 (37)

DOI: 10.1002/adhm.71464 ↗

At a glance

Journal article in Advanced Healthcare Materials, 2026-10. Written by Ali Mousavi and 10 co-authors. Institution: Institute of Biomedical Engineering, Department of Pharmacology and Physiology, Faculty of Medicine, Université De Montréal, Montréal, QC, Canada. Major MEDLINE topics: Cardiomyopathy, Dilated, Myocardial Contraction, Lab-On-A-Chip Devices. 95 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Natural Sciences and Engineering Research Council of Canada, Fonds de Recherche du Québec Santé (FRQS), Wellcome Trust.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Dilated cardiomyopathy (DCM) is the leading cause of heart transplantation, with a 50% risk of progression to heart failure within 5 years. Conventional disease modeling approaches fail to recapitulate the sophisticated function of the human heart. Alternatively, heart‐on‐a‐chip (HOC) platforms enable real‐time monitoring of disease progression and drug responses using miniaturized engineered heart tissues. Here, we developed a functional HOC model using patient‐specific human induced pluripotent stem cells (hiPSCs), reprogrammed from the patients’ blood samples. The chip contains two cell‐seeding chambers with flexible silicone pillars to support tissue formation. Healthy and DCM hiPSCs were differentiated into cardiomyocytes, combined with an optimized ratio of human cardiac fibroblasts, encapsulated in a fibrin/Geltrex hydrogel (containing fluorescent beads), and seeded in the device chambers. The tissue gradually compacted and started beating spontaneously. Immunofluorescence assay revealed structural abnormalities in DCM tissues, including reduced cell alignment and elongation. The tissue functional responses (e.g., calcium transients and beating) were investigated after 2 weeks of culture, revealing arrhythmia‐like behavior in DCM tissue and highlighting functional hallmarks of the disease. Finally, the platform was validated using norepinephrine to assess the functional responsiveness of the tissues. These results demonstrate the potential of this system for disease modeling and future patient‐specific investigations.

Subjects

MeSH terms (MEDLINE)

Cardiomyopathy, DilatedMyocardial ContractionLab-On-A-Chip DevicesHumansInduced Pluripotent Stem CellsMyocytes, CardiacCell DifferentiationMicrophysiological SystemsFibroblastsTissue EngineeringCells, Cultured

Author keywords

dilated cardiomyopathydisease modelingdrug screeningheart‐on‐a‐chiphuman‐induced pluripotent stem cells (hiPSCs)

Authors and institutions

  • Institute of Biomedical Engineering, Department of Pharmacology and Physiology, Faculty of Medicine, Université De Montréal, Montréal, QC, Canada.
  • CHU Sainte-Justine Research Center, Montréal, QC, Canada.
  • Montréal TransMedTech Institute, Montréal, QC, Canada.
  • Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Surgical and Interventional Sciences, Department of Surgery, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
  • eNUVIO Inc., Montréal, QC, Canada.

ORCID profiles: Ali Mousavi, Ludovic Mouttet, Yasaman Hekmatnia, Mehran Mottahedi, Naimeh Rafatian, Houman Savoji

Funding

  • Natural Sciences and Engineering Research Council of Canada
  • Fonds de Recherche du Québec Santé (FRQS)
  • Wellcome Trust
  • Montreal TransMedTech Institute (iTMT)
  • Research Center of CHU Sainte-Justine (CRCHUSJ)
  • University of Montreal, Polytechnique Montreal
  • ThéCell Structuring Project Grant
  • Courtois Cardiovascular Signature Program

Cite

APA

Mousavi, A., Mouttet, L., Cui, S., Hekmatnia, Y., Mottahedi, M., Derish, I., Rafatian, N., Aurousseau, M., Andelfinger, G., Cecere, R., & Savoji, H. (2026). Patient‐Derived 3D Heart‐On‐a‐Chip Model of Dilated Cardiomyopathy With Embedded Bead‐Based Mapping of Tissue Contractility. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71464

Vancouver

Mousavi A, Mouttet L, Cui S, Hekmatnia Y, Mottahedi M, Derish I, et al. Patient‐Derived 3D Heart‐On‐a‐Chip Model of Dilated Cardiomyopathy With Embedded Bead‐Based Mapping of Tissue Contractility. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71464

BibTeX
@article{Mousavi2026,
  author = {Mousavi, Ali and Mouttet, Ludovic and Cui, Shihao and Hekmatnia, Yasaman and Mottahedi, Mehran and Derish, Ida and Rafatian, Naimeh and Aurousseau, Mark and Andelfinger, Gregor and Cecere, Renzo and Savoji, Houman},
  title = {Patient‐Derived 3D Heart‐On‐a‐Chip Model of Dilated Cardiomyopathy With Embedded Bead‐Based Mapping of Tissue Contractility},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71464}
}
Start for free →